Related Experiment Video
Updated: Feb 22, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Phenazopyridine-phthalimide nano-cocrystal: Release rate and oral bioavailability enhancement
Yu Huang1, Jin-Mei Li2, Zhi-Hui Lai3
1School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China; School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.
Abstract:
Both cocrystal and nanocrystal technologies have been widely used in the pharmaceutical development for poorly soluble drugs. However, the synergistic effects due to the integration of these two technologies have not been well investigated. The aim of this study is to develop a nano-sized cocrystal of phenazopyridine (PAP) with phthalimide (PI) to enhance the release rate and oral bioavailability of PAP. A PAP-PI nano-cocrystal with particle diameter of 21.4±0.1nm was successfully prepared via a sonochemical approach and characterized by powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and dynamic light scattering (DLS) analysis. An in vitro release study revealed a significant release rate enhancement for PAP-PI nano-cocrystal as compared to PAP-PI cocrystal and PAP hydrochloride salt. Further, a comparative oral bioavailability study in rats indicated significant improvement in Cmax and oral bioavailability (AUC0-∞) by 1.39- and 2.44-fold, respectively. This study demonstrated that this novel nano-cocrystal technology can be a new promising option to improve release rate and absorption of poorly soluble compounds in the pharmaceutical industry.
Related Concept Videos
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Permeability Enhancement
Modified-Release Drug Delivery Systems: Bioavailability
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

